NCT03643601

A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease

A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease (ASK)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 14,415 (actual)
• Sponsor: Astellas Pharma a/s · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of this study is to describe renal anemia treatment patterns in non-dialysis dependent (ND) and dialysis dependent (DD) populations, with a particular focus on iron use in erythropoiesis stimulating agent (ESA) treated patients. This study will also provide an epidemiological description of chronic kidney disease (CKD) associated anemia in relation to CKD stage, dialysis modality and underlying morbidity, as well as describe the relationship between inflammation and ESA treatment and describe the associated cardiovascular illness in ESA treated patients.

Detailed description

Data from year 2015 will be used for the prevalence analysis.The prevalent population of CKD patients \> 18 years in the Swedish Renal Registry in 2015 both dependent on dialysis (DD) and not on dialysis (ND).

Conditions

• Chronic Kidney Disease Associated Anemia

Interventions

Type	Name	Description
OTHER	Non-Interventional	Epidemiological overview of CKD-associated anemia and treatment patterns, rather than to evaluate specific drugs

Timeline

• Start date: 2018-09-24
• Primary completion: 2018-12-04
• Completion: 2018-12-04
• First posted: 2018-08-23
• Last updated: 2024-10-31

Locations

1 site across 1 country: Sweden